NasdaqGM - Delayed Quote USD
Apogee Therapeutics, Inc. (APGE)
At close: October 21 at 4:00 PM EDT
After hours: October 21 at 7:47 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 6.56M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale at price 56.07 - 56.74 per share. | Direct | 2,249,307 | Oct 2, 2024 |
DAMBKOWSKI CARL Officer | Sale at price 56.16 - 56.86 per share. | Direct | 374,954 | Oct 2, 2024 |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale at price 47.28 - 48.23 per share. | Direct | 1,904,841 | Sep 4, 2024 |
DAMBKOWSKI CARL Officer | Sale at price 47.49 - 48.06 per share. | Direct | 316,969 | Sep 4, 2024 |
HENDERSON JANE Chief Financial Officer | Sale at price 48.26 per share. | Direct | 289,560 | Aug 23, 2024 |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale at price 40.40 - 42.17 per share. | Direct | 1,624,764 | Aug 7, 2024 |
DAMBKOWSKI CARL Officer | Sale at price 40.47 - 42.56 per share. | Direct | 298,336 | Aug 7, 2024 |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sale at price 37.26 per share. | Direct | 558,900 | Jul 5, 2024 |
DAMBKOWSKI CARL Officer | Sale at price 37.29 - 38.16 per share. | Direct | 225,418 | Jul 3, 2024 |
FAIRMOUNT FUNDS MANAGEMENT LLC Director | Purchase at price 17.00 per share. | Indirect | 49,999,992 | Jul 13, 2023 |
SHAH NIMISH P Director | Purchase at price 17.00 per share. | Indirect | 29,750,000 | Jul 13, 2023 |
Related Tickers
SYRE Spyre Therapeutics, Inc.
32.43
-1.01%
PTGX Protagonist Therapeutics, Inc.
45.96
-2.15%
ACLX Arcellx, Inc.
90.28
-6.79%
VERA Vera Therapeutics, Inc.
40.89
-0.66%
KYMR Kymera Therapeutics, Inc.
46.56
+0.32%
DYN Dyne Therapeutics, Inc.
33.48
-4.99%
NMRA Neumora Therapeutics, Inc.
14.05
-14.80%
AGIO Agios Pharmaceuticals, Inc.
45.66
+0.35%
JANX Janux Therapeutics, Inc.
50.49
+0.92%
CGON CG Oncology, Inc.
36.71
+0.74%